IL-22 induces complement protein expression in the liver, and the lack of IL-22 signaling leads to greater dissemination of translocating commensal bacteria following infection.25 However, in contrast to our study, this report observed no significant differences in intestinal damage, suggesting that therapeutically enhancing IL-22 expression via R848 treatment protects through a different mechanism. Here, IL22 is linked to infection.